Bone marrow mononuclear cells enhance anti-inflammatory effects of pravastatin against isoproterenol-induced myocardial infarction in rats

References

• Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rössig L, Spyridopoulos I, Zeiher AM, Dimmeler S. 2003. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res. 92:1049–1055.
   PubMed Web of Science ®Google Scholar
• Das U. 2000. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem. 215:145–152.
   PubMed Web of Science ®Google Scholar
• Frangogiannis N, Smith CW, Entman M. 2002. Inflammatory response in myocardial infarction. Cardiovasc Res. 53:31–47.
   PubMed Web of Science ®Google Scholar
• Gayathri V, Ananthi S, Chandronitha C, Ramakrishnan G, Lakshmisundaram R, Vasanthi H. 2011. Cardioprotective effect of Nerium oleander flower against isoproterenol-induced myocardial oxidative stress in experimental rats. J Cardiovasc Pharmacol Ther. 16:96–104.
   PubMed Web of Science ®Google Scholar
• Grybauskiene R, Karciauskaite D, Brazdzionyte J, Janenaite J, Bertasiene Z, Grybauskas P. 2007. Brain natriuretic peptide and other cardiac markers predicting left ventricular remodeling and function two years after myocardial infarction. Medicina (Kaunas). 43:708–715.
   PubMed Web of Science ®Google Scholar
• Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y. 1995. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation. 92:1558–1564.
   PubMed Web of Science ®Google Scholar
• Hamelin B, Turgeon J. 1998. Hydrophilicity/lipophilicity: Relevance for pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci. 19:26–37.
   PubMed Web of Science ®Google Scholar
• Hoch A, Leach J. 2015. Concise review: Optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications. Stem Cells Transl Med. 4:412.
   PubMedGoogle Scholar
• Hung L, Su M, Chu W, Chiao CW, Chan WF, Chen JK. 2002. Protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with anti-oxidant efficacy. Br J Pharmacol. 135:1627–1633.
   PubMed Web of Science ®Google Scholar
• Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. 2005. Redox regulation of NF-κB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal. 7:395–403.
   PubMed Web of Science ®Google Scholar
• Kaesemeyer W, Caldwell R, Huang J, Caldwell R. 1999. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol. 33:234–241.
   PubMed Web of Science ®Google Scholar
• Kannan M, Quine S. 2013. Ellagic acid inhibits cardiac arrhythmias, hypertrophy, and hyperlipidaemia during myocardial infarction in rats. Metabolism. 62:52–61.
   PubMed Web of Science ®Google Scholar
• Kassan M, Montero M, Sevilla M. 2009. Chronic treatment with pravastatin prevents early cardiovascular changes in spontaneously hypertensive rats. Br J Pharmacol. 158:541–547.
   Google Scholar
• Kocher A, Schuster M, Szabolcs M, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling, and improves cardiac function. Nat Med. 7:430–436.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy G, Smith J, Mukkamala R, Hall K, Joyner W, Yerra L, Chi DS. 1998. Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids. Microvasc Res. 55:189–200.
   PubMed Web of Science ®Google Scholar
• Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K. 2000. HMG-CoA reductase inhibitor simvastatin activates protein kinase Akt and promotes angiogenesis in normo-cholesterolemic animals. Nat Med. 6:1004–1010.
   PubMed Web of Science ®Google Scholar
• Landmesser U, Engberding N, Bahlmann F, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, et al. 2004. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation. 110:1933–1939.
   PubMed Web of Science ®Google Scholar
• Laufs U, La Fata V, Plutzky J, Liao J. 1998. Up-regulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Circulation. 97:1129–1135.
   PubMed Web of Science ®Google Scholar
• Liu M, Wang F, Wang Y, Jin R. 2009. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: The role of inflammation. Cardiovasc Drugs Ther. 23:369–376.
   PubMed Web of Science ®Google Scholar
• Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, Walsh K, Isner JM, Asahara T. 2001. HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells. J Clin Invest. 108:399–405.
   PubMed Web of Science ®Google Scholar
• Lobo Filho H, Ferreira N, Sousa RB, Carvalho ER, Lobo PL, Lobo Filho JG. 2011. Experimental model of myocardial infarction induced by isoproterenol in rats. Rev Bras Cir Cardiovasc. 26:469–476.
   PubMed Web of Science ®Google Scholar
• Lopez A, Murray C. 1998. The global burden of disease, 1990-2020. Nat Med. 4:1241–1243.
   PubMed Web of Science ®Google Scholar
• Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T. 2000. High levels of plasma brain natriuretic peptide and IL-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 36:1587–1593.
   PubMed Web of Science ®Google Scholar
• Mees B, Recalde A, Loinard C, Tempel D, Godinho M, Vilar J, van Haperen R, Lévy B, de Crom R, Silvestre JS. 2011. Endothelial nitric oxide synthase over-expression restores efficiency of bone marrow mononuclear cell-based therapy. Am J Pathol. 178:55–60.
   PubMed Web of Science ®Google Scholar
• Nian M, Lee P, Khaper N, Liu P. 2004. Inflammatory cytokines and post-myocardial infarction remodeling. Circ Res. 94:1543–1553.
   PubMed Web of Science ®Google Scholar
• Panda V, Naik S. 2009. Evaluation of cardioprotective activity of Ginkgo biloba and Ocimum sanctum in rodents. Alt Med Rev. 14:161–171.
   PubMed Web of Science ®Google Scholar
• Patel V, Upaganlawar A, Zalawadia R, Balaraman R. 2010. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic, and histoarchitectural evaluation. Eur J Pharmacol. 644:160–168.
   PubMed Web of Science ®Google Scholar
• Rathore N, John S, Kale M, Bhatnagar D. 1998. Lipid peroxidation and anti-oxidant enzymes in isoproterenol induced oxidative stress in rat tissues. Pharmacol Res. 38:297–303.
   PubMed Web of Science ®Google Scholar
• Ridker P, Rifai N, Pfeffer M, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E. 1998. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 98:839–844.
   PubMed Web of Science ®Google Scholar
• Sahna E, Acet A, Ozer M, Olmez E. 2002. Myocardial ischemia-reperfusion in rats: Reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin. J Pineal Res. 33:234–238.
   PubMed Web of Science ®Google Scholar
• Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, Wen J, Kubota T, Utsumi H, Takeshita A. 2004. Over-expression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation. 109:544–549.
   PubMed Web of Science ®Google Scholar
• Sia Y, Parker T, Liu P, Tsoporis JN, Adam A, Rouleau JL. 2002. Improved post-myocardial infarction survival with probucol in rats: Effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression. J Am Coll Cardiol. 39:148–156.
   PubMed Web of Science ®Google Scholar
• Sorescu D, Griendling K. 2002. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail. 8:132–140.
   PubMedGoogle Scholar
• Stypmann J, Schubert A, Welp H, Schulte H, Assmann G, Breithardt G, Nofer JR. 2008. Atorvastatin therapy is associated with reduced levels of N-terminal pro-hormone brain natriuretic peptide and improved cardiac function in patients with heart failure. Clin Cardiol. 31:478–481.
   PubMed Web of Science ®Google Scholar
• Sun Y. 2007. Oxidative stress and cardiac repair/remodeling following infarction. Am J Med Sci. 334:197–205.
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. 2001. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 103:2885–2890.
   PubMed Web of Science ®Google Scholar
• Vennila L, Pugalendi K. 2010. Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox Reports. 15:36–42.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sjoquist P. 2006. Myocardial regeneration with stem cells: Pharmacological possibilities for efficacy enhancement. Pharmacol Res. 53:331–340.
   PubMed Web of Science ®Google Scholar
• Zbinden S. 2004. Effect of statin treatment on coronary collateral flow in patients with coronary artery disease. Heart. 90:448–449.
   PubMed Web of Science ®Google Scholar